Back
ESC Premium Access

Characteristics and long-term ablation outcomes of supraventricular arrhythmias in hypertrophic cardiomyopathy: a 10-year, single-center experience

Session: Arrhythmias e-posters
Topic: Epidemiology, Prognosis, Outcome
Speaker: Doctor H. ZHANG (Beijing, CN)
Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

About the speaker

Doctor Hong-Da ZHANG

State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular D, Beijing (China)
0 follower

114 more presentations in this session

Low voltage in limb leads in arrhythmogenic cardiomyopathy.

Speaker: Associate Professor S. Peters (Norden, DE)

Access
Abstract
Slides
Thumbnail

Secondary prevention implantable cardioverter-defibrillator (ICD) therapy in octogenarians: effective and safe

Speaker: Doctor C. Hauck (Regensburg, DE)

Access
Abstract
Slides
Thumbnail

Features of changes in left ventricular mechanics in patients with epicardial obesity

Speaker: Doctor O. Gritsenko (Barnaul, RU)

Access
Abstract
Slides
Thumbnail

Heart rate turbulence as potential adjuvant index for optimal treatment guidance in severe pulmonary artery hypertension.

Speaker: Doctor E. Simeonidou (Athens, GR)

Access
Abstract
Slides
Thumbnail

Comparison of clockwise and counterclockwise right atrial flutter using high-resolution mapping

Speaker: Professor A. Da Costa (Saint-Etienne, FR)

Access
Abstract
Slides
Thumbnail

Access the full session

Arrhythmias e-posters

Speakers: Doctor H. ZHANG, Associate Professor S. Peters, Doctor C. Hauck, Doctor O. Gritsenko, Doctor E. Simeonidou...
Access
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress
logo Image

Related content

ESC Premium Access

Culprit-plaque morphology and residual SYNTAX score for predicting cardiovascular events in acute myocardial infarction: an optical coherence tomography study

30 August 2021

ESC Premium Access

Benefits of SGLT2-1/2 Inhibition on Heart Failure, Ischemic, and Kidney Endpoints

27 August 2021

ESC 365 is supported by

logo Novo Nordisk